Evidence exists that BRCA2 carriers may have an elevated risk of breast, ovarian, colon, prostate, and pancreatic cancer. In general, carriers are defined as individuals with protein truncating mutations within the BRCA2 gene. Many Brca2 knockout lines have been produced and characterized in the mouse. We previously produced a rat Brca2 knockout strain in which there is a nonsense mutation in exon 11 between BRC repeats 2 and 3, and a truncated protein is produced. Interestingly, while such a mutation in homozygous mice would lead to limited survival of approximately 3 months, the Brca2 À/À rats are 100% viable and the vast majority live to over 1 year of age. Brca2 À/À rats show a phenotype of growth inhibition and sterility in both sexes. Aspermatogenesis in the Brca2 À/À rats is due to a failure of homologous chromosome synapsis. Long-term phenotypes include underdeveloped mammary glands, cataract formation and lifespan shortening due to the development of tumors and cancers in multiple organs. The establishment of the rat Brca2 knockout model provides a means to study the role of Brca2 in increasing cancer susceptibility and inducing a novel ocular phenotype not previously associated with this gene.
Introduction
Mutation of the highly penetrant tumor suppressor gene BRCA2 has been associated with a wide range of phenotypes, characterized by an increased susceptibility to breast, ovarian and other cancers. In addition, mutant BRCA2 is associated with Fanconi's anemia. Cell culture studies indicate that BRCA2 has several functions, including repair of double-strand breaks (DSBs) in DNA through homologous recombination, as well as regulation of transcription and the cell cycle (reviewed by Yoshida and Miki, 2004) . It is hypothesized that tumor suppression by BRCA2 is related to its ability to repair DSBs through interaction with the RAD51 recombination enzyme (Shivji and Venkitaraman, 2004) . This interaction is mediated by conserved amino-acid motifs (BRC repeats) within exon 11 of BRCA2 (Bork et al., 1996; Bignell et al., 1997) .
While there are in vivo mouse models of human disease to study the inactivation of the Brca2 gene by truncating mutations, the models are somewhat limited by low viability of Brca2 mutant mice. Homozygous mice with severe truncations of the Brca2 protein before exon 11 or resulting in the deletion of this exon are embryonic lethal (reviewed by Moynahan, 2002) . Homozygous Brca2 knockout mice with some of the BRC repeats in exon 11 left intact are infertile, have a limited life span and develop thymic lymphoma (Connor et al., 1997; Friedman et al., 1998) . In contrast, truncation of a small region of the carboxyl end of Brca2 results in fertile animals with no gross abnormalities that are predisposed to cancer (McAllister et al., 2002) , although there is B30% reduced viability than expected for homozygous mice. Other mouse models with improved viability are available, but often require multiple genetic manipulations to improve survivability (reviewed by Moynahan, 2002) . Therefore, we sought to produce an additional genetic tool by using a rat model to study Brca2 function.
Our group has developed a technology that for the first time can produce knockout rats using ENU mutagenesis with a yeast-based screening procedure to identify functional mutations of specific genes (Zan et al., 2003) . The first knockout rat produced was for the Brca2 gene. We previously reported that the ENUinduced nonsense mutation generated a stop codon located 5 0 of the well conserved BRC repeats in exon 11. The major short-term phenotypes previously reported for the homozygous Brca2 knockout rat were stunted growth and sterility in both males and females. Here, we report the long-term phenotypes observed in rat Brca2 knockouts.
Results

Truncated protein
Western blotting with anti-Brca2 indicated the presence of full length Brca2 (B372 kDa) in testes extracts from Brca2 þ / þ and Brca2 þ /À rats ( Figure 1a ). In Brca2 À/À samples, no full length Brca2 band was observed, even with extended exposure of the membrane to the film (not shown). Based on the position of the Brca2 mutation (Zan et al., 2003) , the predicted size of truncated Brca2 protein is B150 kDa. A truncated Brca2 product of the expected size was detected in Brca2 þ /À and Brca2 À/À samples after extended exposure of the lower portion of the blot (Figure 1b ), but was not observed in the Brca2 þ / þ testis.
Growth inhibition phenotype
As was previously reported, Brca2 À/À rats exhibit growth inhibition before weaning and up to 14 weeks of age. This reduction in body weight continues for both Brca2 À/À male and female rats throughout their life span, while Brca2 þ /À rats maintain body weights very similar to the Brca2 þ / þ rats (data not shown). At approximately 1 year of age, the reduction in body weight for Brca2 À/À rats compared to Brca2 þ / þ littermate controls was 33 and 21% for male and females, respectively.
Underdeveloped mammary gland phenotype Brca2
À/À rats are sterile due to ovarian and testicular atrophy (Zan et al., 2003) . In addition, the mammary glands of Brca2 À/À female rats are underdeveloped. Analysis of mammary gland morphology in adult Brca2 female rats (n ¼ 4-5 rats/genotype) revealed that the Brca2 À/À rat mammary gland was smaller and less developed than that from wild-type and heterozygous rats ( Figure 2a ). The Brca2 À/À mammary glands did show estrogen-responsiveness, as the size of mammary glands from Brca2 À/À rats following ovariectomy and estrogen replacement was similar to that of Brca2
and Brca2 þ /À rats given this treatment (Figure 2b ).
Aspermatogenesis
Meiosis in Brca2
À/À rats proceeds normally through leptotene and early zygotene (Figure 3a ) with 40 centromeres clearly identified by CREST antisera (Brenner et al., 1981) . The correct number of centromeres and chromosome cores indicates that sister chromatid cohesion is not affected in the absence of Brca2. Immunostaining for the Scp3/Cor1 protein of axial/lateral elements (Dobson et al., 1994) revealed that homologous chromosomes are not assembled into the synaptonemal complex (Figure 3b ). Even though the chromosomes in arrested Brca2 À/À spermatocytes look rather compact, only limited synapsis could be seen in a fraction of cells. Synapsed regions could be detected by staining for the Scp1/Syn1 protein, a component of the central element of the synaptonemal complex (Dobson et al., 1994) . The most advanced Brca2 À/À spermatocytes show short stretches of synapsed regions, presumably between nonhomologous chromosomes. Cells with rather extensive synapsis are rare.
Spo11-mediated DSBs initiate meiotic homologous recombination and the repair of these breaks is required for chromosome synapsis in most organisms including mammals (Roeder, 1997; Zickler and Kleckner, 1999; Keeney, 2001; Villeneuve and Hillers, 2001) . The appearance of the breaks in leptotene is accompanied by the phosphorylation of histone H2ax over megabasesize chromatin regions (Mahadevaiah et al., 2001) . In Brca2 þ / þ rat spermatocytes this stage can be easily recognized by anti-gH2ax (phosphorylated H2ax) antibodies that produce a cloud-like staining pattern all over the chromatin (Figure 4a ). By pachytene (Figure 4b ), gH2ax staining remains only in the sex body region (Eijpe et al., 2000; Mahadevaiah et al., 2001) . Brca2 À/À spermatocytes show extensive gH2ax staining that persists to the most advanced stages with the maximum extent of synapsis (Figure 4c and d) . These data indicate that DSBs are generated in the Brca2 À/À knockout spermatocytes but are not repaired.
Cancer/tumor incidence in Brca2
À/À rats N2 Â N2 male and female rats were followed for up to 24 months to determine if tumors and/or other pathologies would develop in the Brca2 À/À animals, compared with Brca2 þ /À and þ / þ littermate controls. Some animals were necropsied before this time point, if signs of morbidity were observed. This was true for many Brca2 À/À rats, as they developed a variety of tumors and/or appeared moribund around 1 year of age. The average life span (Figure 5a ) for Brca2 À/À males (n ¼ 16) was 14 months of age compared to 21 months for Brca2
À/À females (n ¼ 33) had an average lifẽ span of 15 months of age versus 20-21 months for Brca2
The majority of rats on this long-term phenotyping study were necropsied and examined for disease. Cancer/tumor incidence was significantly increased in both male and female Brca2 À/À rats, compared with Brca2 þ / þ controls or heterozygous rats (Po0.0001, Fisher's exact test). In male Brca2 À/À rats, cancer/tumors were identified in 73% (11/15) of the rats examined, in contrast to Brca2 þ /À and þ / þ male rats, in which only 5% (2/40) and 0% (0/14) respectively, developed some type of abnormality. A similar trend of significantly increased cancer/tumor incidence of 67% (18/27) was seen in Brca2 À/À female rats. Brca2 þ /À and Brca2
females had a cancer incidence of 12% (6/52) and 15% (4/27), respectively, due exclusively to cancers/tumors of the mammary gland ( Figure 5d ). As the number of benign mammary lesions in these rats was high, the analysis here includes only mammary carcinomas. Surprisingly, the frequency of mammary carcinoma development between females of the three Brca2 genotypes was similar despite the observation that mammary glands of the Brca2 À/À rats are underdeveloped and ovarian function appears to be limited in these rats.
The most prevalent tumor types observed in Brca2 sternum, and in four cases, the sarcomas metastasized to lung tissue. In addition, approximately 20% of female Brca2 À/À rats developed ovarian tumors, including granulosa cell tumors and thecomas (Figure 6b and c).
Cataract formation
At approximately 6-9 months of age, cataracts were visible in several of the Brca2 À/À rats, while none were seen in heterozygous or wild-type controls. Clinical assessment of ocular pathology was carried out on Brca2 À/À (n ¼ 78 eyes, 39 rats), Brca2 þ /À (n ¼ 12 eyes, 6 rats), and Brca2 þ / þ (n ¼ 12 eyes, 6 rats) rats of 11-14 months of age by slit lamp examination. Greater than 90% of Brca2 À/À rats showed various anterior segment disorders, whereas Brca2 þ /À or Brca2 þ / þ rats did not. Cataracts, including cortical and anterior, were observed in >90% of the Brca2 À/À rats. Collapsed anterior chamber was observed in 23% of the Brca2 À/À rats and synechiae were observed in 38% of the Brca2 À/À rats ( Figure 6d ). Histopathologic assessment of eyes from Brca2 À/À rats was consistent with findings of the slit lamp examination. Analysis of hematoxylin and eosinstained sections showed various cataracts (cortical, anterior, equatorial and posterior) in 84% (11/13) of the Brca2 À/À animals. A variety of other abnormalities including synechiae, lens mineralization, posterior lens capsule rupture and anterior segment dysgenesis also were frequently observed.
Discussion
Rat knockout models have the potential to not only complement mouse knockouts, but also identify novel phenotypes and gene functions in models of human disease. The first knockout rat produced was for the Brca2 tumor suppressor gene. As previously reported, short-term phenotypic analysis of the Brca2 knockout rats showed that heterozygous animals could be bred to yield viable homozygous offspring despite having a severe protein truncation in the beginning of exon 11 that removes all highly conserved BRC repeats (Zan et al., 2003) .
This exon 11 mutation in the Brca2 gene was predicted to produce a truncated Brca2 product of approximately 150 kDa (Zan et al., 2003) . We did not detect full-length or truncated Brca2 product in the spleens, kidneys, mammary glands or ovaries of animals from all Brca2 gentoypes (data not shown), presumably due to low expression levels. Therefore, we cannot speculate as to the potential for truncated Brca2 products with reduced or alternative functions in these or other tissues. We assessed for truncated Brca2 products in the testes, due high expression levels of Brca2 in this tissue. A weakly expressed band of the expected size was observed in the testes samples from Brca2 À/À and Brca2 þ /À rats but not in the wild-type. No full-length Brca2 was found in Brca2 À/À samples. Expression of the truncated product was higher in the Brca2 þ /À testes extracts compared with the Brca2 À/À samples despite loading equal amounts of total protein. This finding may be due to the dilution of proteins from apoptotic spermatocytes in Brca2 À/À extracts by those expressed in viable cells. This is consistent with our previous observation of the lack of mature sperm cells in Brca2 À/À testes (Zan et al., 2003) . Analysis of the infertility in Brca2 À/À male rats revealed that aspermatogenesis was caused by the failure of homologous chromosome assembly at the synaptonemal complex. Current models (Allers and Lichten, 2001; Villeneuve and Hillers, 2001) suggest that the major event in meiotic recombination is the Rad51/ Dmc1-mediated homology search followed by the single end invasion (Hunter and Kleckner, 2001 ) of the intact À/À rats, compared with heterozygous and wild-type rats.
Increased incidence of various tumors/cancers in male (c) and female (d) Brca2
À/À knockout rats is also observed.
Brca2 knockout rat model MS Cotroneo et al homologous chromosome. Rad51 and Dmc1 are believed to load onto the single-stranded ends of resected DSBs and can be observed as numerous foci on the chromosome cores. These foci disappear in pachytene, when the breaks are successfully repaired. Previous studies showed a decrease in Rad51 and Dmc1 foci in infertile Brca2 knockout mice rescued from embryonic lethality by expression of human BRCA2 gene (Sharan et al., 2004) . However, rat Brca2 À/À spermatocytes are completely devoid of either Rad51 or Dmc1 foci (data not shown). This finding is in agreement with a proposed role of BRCA2 in transporting Rad51 and Dmc1 to the sites of DNA damage (Davies et al., 2001; Siaud et al., 2004) . Taken together, the observations of infertility, aspermatogenesis and meiotic prophase arrest suggest that the truncated Brca2 protein product identified in the rat testis is not functional. Interestingly, meiotic arrest during prophase is commonly observed in the testes of men with azoospermia (Schulze et al., 1999) , and a potential association between the common BRCA2 variant N372H has been identified in infertile men with azoospermia or oligospermia (Zhoucun et al., 2006) . Therefore, this cell-specific function of BRCA2 identified in rodents may have implications in human infertility.
Although Brca2 À/À rats are sterile and have lower body weights compared to Brca2 þ /À and Brca2 þ / þ rats, all homozygous knockouts survive into adulthood. This finding is in contrast to homozygous Brca2 knockout mice with similar mutations as these mice die early (reviewed by Moynahan, 2002 Brca2 knockout rat model MS Cotroneo et al possibility that the observed phenotypes were derived from 'passenger' mutations caused by ENU. We were able to both confirm Brca2 related phenotypes observed in various mouse models and also extend these observations to a novel phenotype. Male and female Brca2 À/À rats were followed for their lifetime survivability and cancer incidence. In comparison to the Brca2 þ /À and Brca2 þ / þ rats, the Brca2 À/À rats had a substantial reduction in lifespan for both sexes. At least part of this reduction in lifespan could be attributed to an increase in cancer development. The male Brca2 À/À rats developed B15 times the number of tumors or cancers developing in the Brca2 þ /À and Brca2 þ / þ rats. A similar trend also occurred in the female rats. The most prevalent tumor type in male Brca2 À/À rats was sarcoma of the stomach, bone and muscle. Tumors arising most frequently in female Brca2 À/À rats were osteosarcomas and ovarian tumors.
Brca2
À/À female rats (20%) developed ovarian tumors, including those of the thecal and granulosa cells.
Notably, osteosarcoma development in both male and female Brca2 À/À rats occurred at a frequency of 20%, a site not common in the limited surviving mice having terminal deletions of exon 11 (Connor et al., 1997; Friedman et al., 1998) . Homozygous deletion of exon 27 in mice resulted in the development of various epithelial carcinomas, lymphomas and sarcomas however, no osteosarcomas and only one ovarian tumor were reported (McAllister et al., 2002) . In contrast, further studies showed significantly more osteosarcomas in homozygous mice lacking exon 27 than in their heterozygous or wild-type counterparts, an effect that was greatly enhanced when the mice were also heterozygous for mutant p53 (McAllister et al., 2006) . These authors point out that tumor spectrum in these models may be affected by the background strain genetics. It is also plausible to hypothesize that diminished DSB repair by lack of functional Brca2 may play a role in the development of osteosarcomas in Brca2 À/À rats, as accumulation of DSBs can result in chromosomal translocations, a common finding in human sarcomas and hematologic malignancies (reviewed by Elliott and Jasin, 2002) . Further analysis of tumors from Brca2 À/À rats is needed to determine if their etiology is a direct result of loss of Brca2 function.
It is important to note that Brca2 À/À females did not show increased propensity to develop mammary carcinomas, which may be due to the inhibition of mammary development resulting from lack of ovarian differentiation. Short-term estrogen replacement enhanced mammary development in ovariectomized Brca2 À/À females. It is possible that if endocrinologic deficiencies could be restored long-term, increased mammary carcinoma development might be observed.
Finally, we observed ocular phenotypes that have not been previously reported to be associated with the inactivation of Brca2 function. Most striking was the high incidence of cataracts in Brca2 À/À rats, which may be a consequence of diminished repair of DSBs in the lens epithelium. Unrepaired DNA damage to the epithelial cells of the lens is thought to be related to cataract etiology (Worgul et al., 1991) . Similarly, agents causing SSBs and DSBs, such as ionizing radiation received through therapeutic total body irradiation (Zierhut et al., 2000) or space travel (Cucinotta et al., 2001) , are associated with increased susceptibility to cataract formation. Cells deficient in BRCA2, including those derived from mouse models with C-terminal truncating mutations show sensitivity to DSB formation, chromosomal damage, and cell death resulting from ionizing radiation (reviewed by Pellegrini and Venkitaraman, 2004) .
Evidence from knockout mouse models of genes that interact with the BRCA2 pathway, such as ataxiatelangioectasia (Atm) and Fanconi Anemia (FA), also suggests that ocular abnormalities may arise from inefficient DSB repair. Mice heterozygous for the Atm gene are sensitive to radiation-induced cataracts (Worgul et al., 2002) and homozygous Fancd2 knockout mice have micropthalmia (Houghtaling et al., 2003) . In addition to abnormal ocular pathology, these models share other phenotypic similarities to the Brca2 À/À rat, including infertility and meiotic arrest during spermatogenesis in Atm À/À mice (Barlow et al., 1998) . In addition, Fancd2 homozygous knockouts display a small body type, along with abnormal meiotic chromosomal pairing during spermatogenesis (Houghtaling et al., 2003) .
The phenotype of increased cataractogenesis in female Brca2 À/À rats could also be influenced by their deficient gonadal steroid hormone production, similar to the increased risk of age-related cataracts that occurs in postmenopausal women (Klein et al., 1998) . In a rat model for age-related cataractogenesis, estrogen replacement was protective against cataracts induced by methylnitrosourea in ovariectomized Sprague Dawley (SD) rats (Bigsby et al., 1999) . Interestingly, estrogen treatment reduced the latency of radiation-induced cataract formation in SD rats (Dynlacht et al., 2006) , pointing to potential differences between the etiology of age-related and radiation-associated cataracts. Insufficient gonadal steroid production must also be considered as a potential causative factor for cataractogenesis in male rats, although the effect may be androgen related. Further characterization of the Brca2 À/À rat model will aid in determining if the phenotype of increased cataract formation is a primary effect from Brca2 deficiency, a secondary effect from abnormal steroidogenesis, or a combination of both factors.
In summary, this rat model provides an important opportunity to study the functions of Brca2 in late adult life by overcoming the embryonic lethality observed in similar mouse models. This increase in longevity is likely due to the unique genetic background provided by the rat. Many of the phenotypic traits we observed in Brca2 À/À rats are similar to those seen in mouse models, including decreased survivability, increased cancer incidence, growth inhibition, infertility and meiotic arrest during spermatogenesis. However, the most common sites of tumor formation differ from those seen in mice with exon 11 truncating Brca2 mutations, and the increased incidence of ocular lesions and cataracts have not been observed in mouse models with disrupted Brca2 function. It is also important to note that some diseases that occur naturally in aging rats, such as cataracts (Mohr et al., 1994) and carcinogenesis (Nakazawa et al., 2001) , occur with higher frequency in Brca2 À/À rats than in Brca2 þ /À or Brca2 þ / þ animals, and may be related to the role of Brca2 in maintaining genomic integrity. As these studies were carried out in the outbred SD rat strain, future studies using inbred strains carrying the Brca2 mutation will be useful in assessing the effect of genetic background on the phenotype. Additional studies will also allow us to determine if these phenotypes are directly or indirectly due to the absence of Brca2 and to identify specific functions in novel tissues.
Materials and methods
Animals
Rats were maintained in an AALACC-approved facility and all protocols were approved through the University of Wisconsin Medical School Animal Care and Use Committee. Rats were group-housed, fed Teklad lab blox chow and acidified water ad libitum and maintained in a 12-h light/dark cycle.
The methods used to produce the Brca2 knockout founder #3938 male rat have been previously published (Zan et al., 2003) . This rat was bred to outbred SD (Harlan SpragueDawley, Madison, WI, USA) female rats to produce N1 pups. These N1 Brca2 þ /À carrier rats were bred to SD female rats to produce N2 pups. The N2 Brca2 þ /À carriers were bred together to produce N2 Â N2 homozygous, heterozygous and littermate control rats for long-term phenotyping. Rats were assessed for tumor/cancer incidence at 24 months of age, or earlier if appearing sick or moribund. Statistical analyses of tumor/ cancer incidence were carried out using Fisher's exact test with R software (http://www.r-project.org/). Genotyping A small tail tip section from each rat was removed at 1-4 weeks of age. Isolation of DNA was carried out as described previously (Samuelson et al., 2003) . Genomic DNA was PCR amplified using the following primers: FP3435 5 0 -TCA TAA CTT AAC GCC CAG CC-3 0 and RP5267 5 0 -AAG GCA TTT CCT GCA AAA TC-3 0 . A 10 ml reaction was used containing 1 Â reaction buffer, 200 mM dNTPs, 2.5 ng/ml of each primer, 0.5 U Herculase and 1 ml of diluted DNA (B50-100 ng). Each reaction was denatured for 2 min at 951C followed by 35 cycles of 921C for 1 min, 601C for 45 s, 721C for 4 min and a final extension at 721C for 7 min. PCR products were cleaned up using ExoSAP-IT. The final sequencing reaction included 4 ml of the purified PCR product and 16 ml of sequencing master mix, consisting of 1 Â dilution buffer, 1 ml BigDye Terminator (Applied Biosystems), and 0.25 mM of the following primer: SEQ3997 5 0 -AGT AAG TGC CAG GTA ACA GTA. Each 20 ml reaction underwent an initial denaturation of 3 min at 951C followed by 40 cycles of 951C for 30 s, 451C for 30 s, 521C for 4 min, and a final extension at 721C for 7 min. These reactions were analysed using capillary based, automated DNA sequencer platforms.
Brca2 protein expression in rat testes
Testes were collected from adult male Brca2
þ /À and Brca2 þ / þ rats. Proteins were extracted following homogenization in buffer containing 50 mM HEPES, 150 mM NaCl, 10% glycerol, 1% Triton-X 100, 10 mM EGTA, 1 mM dithiothreitol, 10 mM Na 4 P 2 O 7 and 15 mM MgCl 2 , with phosphatase inhibitors (200 mM sodium vanadate, 100 mM NaF, 80 mM sodiumglycerolphosphate) and protease inhibitors (1 mg/ml pepstatin, 2.5 mg/ml aprotinin, 5 mg/ml leupeptin). Following centrifugation to remove debris, the total protein concentration in each extract was determined (BCA Assay, Pierce, Rockford, IL, USA). Samples were then boiled for 5 min in an equal volume of SDS sample buffer containing 10% beta-mercaptoethanol. An equal amount of total protein (100 mg) per sample was separated using sodium dodecyl sulfate-polymerase chain reaction (SDS-PAGE) on 5% acrylamide gels and electroblotted onto nitrocellulose membranes using conditions described previously (Sarkisian et al., 2001) . Immunoblotting for Brca2 was carried out using 2 mg/ml polyclonal antiserum directed against amino acids 19-135 of mouse Brca2 (BRCA2A), provided by Lewis A Chodosh, University of Pennsylvania Cancer Center, using protocols detailed elsewhere (Sarkisian et al., 2001) . Following incubation with a 1/3000 dilution of goat-anti-rabbit secondary antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA), the signal was detected with chemiluminescence detection reagents (Pierce) on X-ray film. Mouse testis protein extract was used as a positive control.
Estrogen replacement
Male Brca2 þ /À carriers (N3 generation) were backcrossed to female SD rats to obtain Brca2 þ /À N4 generation carriers. The backcrossing of carriers was continued until the N8 generation, where heterozygous breeding pairs were collected. Female N8 Â N8 Brca2
þ /À and Brca2 þ / þ offspring (n ¼ 4-6/ group) were used for estrogen replacement studies. At 6 weeks of age, rats were bilaterally ovariectomized and implants containing beta-estradiol (Sigma, St Louis, MO, USA) were placed the interscapular area. Estrogen implants were prepared in 1 cm lengths of Silastic brand (i.d. 0.062 00 , o.d. 0.125 00 ) (Dow Corning, Midland, MI, USA) tubing sealed with medical adhesive. This dose was previously shown to achieve circulating estradiol concentrations that approximated physiological levels for SD rats (Bigsby et al., 1999) . After 6 weeks of estrogen replacement, animals were necropsied for analysis of mammary gland morphology. Age-matched control rats that did not undergo ovariectomy or estrogen treatment were used for comparison. Aluminum carmine-stained mammary whole mounts were prepared as previously described (Brown and Lamartiniere, 1995) and observed under light microscopy. Photographs were taken without magnification using a SONY digital camera.
Aspermatogenesis characterization
Anti-Scp3 mouse polyclonal antibodies were raised against a GST fusion of the full-length rat Scp3 protein. Anti-gH2AX antibodies were from Trevigen (Gaithersburg, MD, USA); anti-Rad 51 and anti-Dmc 1 were from Santa Cruz Biotechnology (Santa Cruz, CA, USA) (H92 and C-20, respectively). Rabbit anti-Scp1 antibody was a gift from C Hoog (Liu et al., 1996) and human CREST antisera was a gift from B Brinkley (Brenner et al., 1981) . Secondary antibodies were from Jackson IR laboratories (Westgrove, PA, USA). The primary antibody were used at the following dilutions: anti-SCP3 -1:800, antigH2AX -1:100, anti-Rad51 -1:50, anti-Dmc1 -1:100, antiScp1 -1:100, CREST antiserum -1:500.
The protocol for meiotic chromosome spreads was modified from the procedure described by Moens et al., 1998 . Following removal of the testicular capsule, seminiferous tubules were finely chopped with a scalpel in RPMI 1640 high-glucose media (GIBCO-BRL, Gaithersburg, MD, USA). The cells were released from the tubules by gently pipetting in and out and filtered through a Falcon 40 mm cell strainer (BD Biosciences, San Jose, CA, USA). The suspension was centrifuged for 8 min at 800 g, the cells were resuspended in RPMI and pelleted. The pellet was resuspended in 0.5% NaCl after removal of any residual media. Cell suspension (15 ml) was added to the glass slides with hydrophobic rings (BD Biosciences, San Jose, CA, USA), and the cells were allowed to adhere without drying out for 10-15 min. Following fixation in 2% paraformaldehyde, slides were exposed to 0.03% SDS for 3 min, 2% paraformaldehyde for 3 min, washed three times in 0.4% Photo-Flo 200 (Kodak, Rochester, NY, USA) for 1 min and air dried. The slides were stored at À201C.
For immunostaining, slides were incubated with blocking solution (10% donkey serum, 3% BSA and 0.05% Triton X-100 in PBS) for 20 min at 371C in a humidity chamber. Primary antibodies were diluted in blocking buffer and incubated under the same conditions for 1-2 h. After two 5 min washes in 0.4% Photo-Flo/PBS solution, slides were blocked for an additional 5 min and incubated with secondary antibodies for 20 min at 371C. The slides were washed twice with 0.4% Photo-Flo in PBS, rinsed twice with 0.4% PhotoFlo and allowed to air dry. Vectashield Mounting Medium with DAPI (Vector Laboratories, Burlingame, CA, USA) was added for coverslipping, and the slides were viewed with a Leica fluorescent microscope. Images were captured at Â 1000 magnification with OpenLab software and processed using Adobe Photoshop.
Evaluation of ocular pathology
At approximately 8-11 months of age, a random subset of Brca2
þ /À and Brca2 þ / þ rats were examined for ocular pathology using a Kowa SL-2 hand held slit lamp and ophthalmoscope. The rats were given a drop of 1% atropine in each eye to dilate the pupil/relax the lens and restrained for approximately 1-3 min for the examination. At necropsy, eyes were fixed in 10% buffered formalin and processed for embedding in paraffin. Sections (5 mm) were cut and stained with hematoxylin and eosin and viewed by light microscopy.
